The physiological action of gliclazide: beta-cell function and insulin resistance.
There is continuing debate about the physiological mechanisms of the action of sulphonylureas in man. In those patients taking sulphonylureas insulin secretion can be demonstrated to be higher, but there are also data which have been interpreted as evidence that these drugs may cause an alteration i...
主要な著者: | Matthews, DR, Hosker, J, Stratton, I |
---|---|
フォーマット: | Journal article |
言語: | English |
出版事項: |
1991
|
類似資料
-
Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man.
著者:: Matthews, DR, 等
出版事項: (1985) -
Application of structural model of glucose-insulin relations to assess beta-cell function and insulin sensitivity.
著者:: Turner, R, 等
出版事項: (1990) -
Continuous infusion of glucose with model assessment: measurement of insulin resistance and beta-cell function in man.
著者:: Hosker, J, 等
出版事項: (1985) -
Similar reduction of first- and second-phase B-cell responses at three different glucose levels in type II diabetes and the effect of gliclazide therapy.
著者:: Hosker, J, 等
出版事項: (1989) -
The stimulation of insulin secretion in non-insulin-dependent diabetic patients by amino acids and gliclazide in the basal and hyperglycemic state.
著者:: Matthews, DR, 等
出版事項: (1997)